Clinical Insights

Exclusive roundtable panels featuring expert voices and moderated by the Oncology Brothers—offering practical, cross-disciplinary perspectives on treatment decisions, toxicity management, and emerging issues in community care.
Big insights, small panels—multidisciplinary strategies for tackling real-world oncology challenges.

BLADDER CANCER

Browse all BLADDER CANCER

BLADDER CANCER

Practice-Changing Insights From the NIAGARA Trial

Petros Grivas, MD, PhD

BLADDER CANCER

NIAGARA Trial: Perioperative Durvalumab Enhances DFS in MIBC

Joshua Meeks, MD, PhD

BLADDER CANCER

The Oncologist’s Role in Counseling Patients With MIBC Through Complex Treatment Decisions

Karine Tawagi, MD

BLADDER CANCER

Key Takeaways From the NIAGARA Trial for Patients With MIBC

Neal Shore, MD, FACS

LUNG CANCER

Browse all LUNG CANCER

LUNG CANCER

Key Takeaways From IMforte for Clinicians Treating ES-SCLC

Ticiana Leal, MD, Stephen Liu, MD, Isabel Preeshagul, DO, MBS, Rahul Gosain, MD, MBA, Rohit Gosain, MD

LUNG CANCER

Sequencing Lurbinectedin in ES-SCLC with CNS Involvement

Ticiana Leal, MD, Stephen Liu, MD, Rahul Gosain, MD, MBA, Rohit Gosain, MD

LUNG CANCER

Managing Lurbinectedin Adverse Events in ES-SCLC Maintenance Therapy

Isabel Preeshagul, DO, MBS, Stephen Liu, MD, Rahul Gosain, MD, MBA, Rohit Gosain, MD

LUNG CANCER

Clinical Relevance of IMforte Survival Data in ES-SCLC

Ticiana Leal, MD, Stephen Liu, MD, Rahul Gosain, MD, MBA, Rohit Gosain, MD